Dr. Vatsayan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Children's National Hospital, 111 Michigan Ave NW
Washington, DC 20010Phone+1 202-476-6690
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2017 - 2019
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Hematology/Oncology, 2013 - 2016
Maimonides Medical Center/Infants and Children's Hospital of BrooklynResidency, Pediatrics, 2010 - 2013
Kasturba Medical College ManipalClass of 2005- University Hospitals Cleveland Medical CenterPost-Doctoral Fellowship, Pediatric BMT/Immunotherapy
Certifications & Licensure
VA State Medical License 2021 - 2026
MD State Medical License 2024 - 2025
DC State Medical License 2019 - 2024
OH State Medical License 2013 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of PediatricsPediatric Hematology/Oncology
Clinical Trials
- A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia Start of enrollment: 2017 Nov 03
Roles: Principal Investigator, Contact
- A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu... Start of enrollment: 2024 Jun 26
Roles: Contact
Publications & Presentations
PubMed
- 8 citationsAmifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myelomaEhsan Malek, Vinita Gupta, Richard J. Creger, Paolo Caimi, Anant Vatsayan
Leukemia & Lymphoma. 2018-01-02 - 68 citationsImmune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.Melissa R Hines, Tristan E Knight, Kevin O McNerney, Mark B Leick, Tania Jain
Transplantation and Cellular Therapy. 2023-07-01 - 17 citationsAnakinra utilization in refractory pediatric CAR T-cell associated toxicities.Caroline Diorio, Anant Vatsayan, Aimee C Talleur, Colleen Annesley, Jennifer J Jaroscak
Blood Advances. 2022-06-14
Journal Articles
- Successful Reduced Intensity Hematopoietic Cell Transplant in a Patient with Deficiency of Adenosine Deaminase 2H Hashem, A Vatsayan, Nature
Press Mentions
Anakinra Shows Promise as Steroid-Sparing Agent for CAR T-cell Therapy-Related ToxicitiesApril 5th, 2021
Professional Memberships
- Member
- ISCTMember
- ASTCTMember
- COGMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
